Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dolasetron mesilate |
Is a |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Product containing dolasetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
1 |
Dolasetron mesilate 20 mg powder for solution for injection ampoule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Dolasetron mesylate monohydr 50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Dolasetron mesylate monohydr 100mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Dolasetron mesilate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Dolasetron mesilate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Dolasetron mesilate 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Product containing dolasetron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
1 |
Dolasetron-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
1 |
Dolasetron mesilate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
|
Product containing only dolasetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
1 |
Dolasetron only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
1 |
Dolasetron only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Some |
1 |